Denver CO 子宫内膜癌临床试验
15项针对 子宫内膜癌的研究正在 Denver及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Rocky Mountain Cancer Center, Denver
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- SCRI at HealthOne, Denver
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
招募中2 期
- AdventHealth Porter, Denver
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
招募中1 期
- SCRI at Denver Health, Denver
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
招募中1/2 期
- SCRI at HCA Health One, Denver
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
招募中1 期
- SCRI Denver, Denver
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
招募中1 期
- Sarah Cannon Research Institute (SCRI) at HealthONE-Denver, Denver
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
招募中1 期
- Normunity Investigational Site, Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- Rocky Mountain Cancer Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- Sarah Cannon Research Institute at HealthONE, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute, Denver
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Denver
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE, Denver
其他城市的 子宫内膜癌试验
- Houston, TX68 项研究
- New York City, NY52 项研究
- Boston, MA50 项研究
- Arlington, VA39 项研究
- Nashville, TN38 项研究
- Los Angeles, CA34 项研究
- St. Louis, MO29 项研究
- Philadelphia, PA28 项研究
- San Antonio, TX27 项研究
- Columbus, OH25 项研究
- Chicago, IL25 项研究
- Oklahoma City, OK25 项研究
Denver的其他研究
- 转移性癌症29 项研究
- 乳腺癌29 项研究
- 非小细胞肺癌27 项研究
- 多发性骨髓瘤27 项研究
- 结直肠癌23 项研究
- 黑色素瘤19 项研究
- 前列腺癌19 项研究
- 癌症(所有类型)18 项研究
- 卵巢癌16 项研究
- 肺癌16 项研究
- 非霍奇金淋巴瘤14 项研究
- 胰腺癌13 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。